The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death

Canadian Journal of Cardiology

Volumn 16, Issue SUPPL. C, 2000, Pages

  Talajic, Mario ^a   Mitchell, L Brent ^a   Hadjis, Tomy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATOR; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MORTALITY; PATIENT SELECTION; REVIEW; SUDDEN DEATH; SURVIVAL RATE;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; INCIDENCE; PATIENT SELECTION; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 0034201573     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Brown CG, Martin DR, Pepe PE, et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992;327:1051-5.
2. Stielt IG, Hebert PC, Weitzman BN, et al. High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992;327:1045-50.
3. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993;119:1187-97.
4. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;334:1993-2040.
5. Bigger JT, for the CABG Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery graft surgery. N Engl J Med 1997;337:1569-75.
6. Bigger JT Jr, Whang W, Rottman JN, et al. Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Ciculation 1999;99:1416-21.
7. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G, and the MUSTT Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
8. Moss AJ, Cannom DS, Daubert JP, et al. Multicenter Automatic Defibrillator Implantation Trial II (MADIT II); design and clinical protocol. Ann Noninvas Electrocardiol 1999;4:83-91.
9. Bardy GH, Lee KL, Mark DB, and the SCD-HeFT Pilot Investigators. The Sudden Cardiac Death in Heart Failure Trial: pilot study. PACE 1997;20:1148. (Abst)
10. Raviele A, Bongiomi MG, Brignole M, et al. Which strategy is "best" after myocardial infarction? The beta-blocker strategy plus implantable cardioverter defibrillator trial: rationale and study design Am J Cardiol 1999;83:104D-11D.